Unlike its pro-tumorigenic function in PanIN and PDA, NRF2 seems to suppress IPMN formation through redox-independent mechanisms, potentially by modulating transcriptional and metabolic programs associated with mucinous differentiation. This evidence concerns the gene NFE2L2 and pancreatic intraductal papillary-mucinous neoplasm.